AbbVie: Has the Humira Cloud Lifted?
September 28, 2017 at 12:46 PM EDT
Shares of AbbVie are rising after the drug maker and rival Amgen announced a settlement regarding the launch of a biosimilar version of Humira.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.